0 items

in your cart

  • Search for Medications
  • Viewcart | Checkout
  • Manage Account
  • Click-to-Call  

Prescription Drug Search

Strengths available for Osimertinib :

Osimertinib 40mg
Osimertinib 80mg

Search for a drug:


Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about GlobalPharmacyMeds.to

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Osimertinib:

  • Antigua and Barbuda
  • Argentina
  • Bangladesh
  • Barbados
  • Bulgaria
  • China
  • Cuba
  • Cyprus
  • Denmark
  • Dominican Republic
  • Ecuador
  • Finland
  • Gibraltar
  • Greece
  • Grenada
  • Guadeloupe
  • Guam
  • India
  • Iran
  • Ireland
  • Italy
  • Jamaica
  • Japan
  • Korea, Republic of
  • Liechtenstein
  • New Zealand
  • Norway
  • Paraguay
  • Portugal
  • Russian Federation
  • Slovakia
  • South Africa
  • Spain
  • Sri Lanka
  • Thailand
  • Tunisia
  • United Arab Emirates
  • United Kingdom, UK
  • United States, US
  • Uruguay
View All Countries

Latest news releases on Osimertinib:

TAGRISSO® (osimertinib) | Official Global Site

Discover the new first-line TAGRISSO efficacy (PFS) data in NSCLC and access information about safety, MOA, dosing, AURA3 and other resources

Nutzenbewertungsverfahren zum Wirkstoff Osimertinib ...

Anwendungsgebiet gemäß Fachinformation für Osimertinib (Tagrisso®) Tagrisso ist angezeigt zur Behandlung von erwachsenen Patienten mit lokal fortgeschrittenem ...

FDA approves osimertinib for first-line treatment of ...

On April 18, 2018, the Food and Drug Administration approved osimertinib (Tagrisso, AstraZeneca Pharmaceuticals LP) for the first-line treatment of patients with ...

Osimertinib or Platinum–Pemetrexed in EGFR T790M ...

Osimertinib is an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) that is selective for both EGFR-TKI sensitizing and T790M resistance mutations ...

Osimertinib With or Without Bevacizumab in Treating ...

Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases

ELCC 2016 News: Osimertinib Combined With Durvalumab in ...

Results from exploratory trial of evaluation of combination treatment

Osimertinib as First-Line Treatment in EGFR-Mutated Non ...

Editorial from The New England Journal of Medicine — Osimertinib as First-Line Treatment in EGFR-Mutated Non–Small-Cell Lung Cancer

TAGRISSO 40 mg film-coated tablets - Summary of Product ...

TAGRISSO 40 mg film-coated tablets - Summary of Product Characteristics (SmPC) by AstraZeneca UK Limited

FDA Expands Approval of Roche Cobas Test as CDx for EGFR ...

The FDA approved its use with tissue or plasma biopsies, giving clinicians a non-invasive option to conduct a test that provides results in a day.

TAGRISSO® (osimertinib) - Treatment for Non-Small Cell ...

Learn about TAGRISSO® (osimertinib), a once-daily prescription treatment for people with metastatic non-small cell lung cancer (NSCLC) with abnormal EGFR genes.

Customer Service
1-866-799-3435 (Use ref# 10786) | Contact Form
Copyright © 2018 GlobalPharmacyMeds.to All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK